Organon & Co. OGN
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -3.21% | -2.45% | -2.08% | -2.92% | -1.69% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -3.21% | -2.45% | -2.08% | -2.92% | -1.69% |
| Cost of Revenue | 1.22% | 5.00% | 5.92% | 5.58% | 4.41% |
| Gross Profit | -6.73% | -8.14% | -8.04% | -9.07% | -6.05% |
| SG&A Expenses | -2.12% | -2.85% | -0.86% | -1.72% | 4.17% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -1.03% | 0.24% | 1.11% | 0.35% | 2.49% |
| Operating Income | -11.14% | -12.06% | -13.06% | -13.63% | -14.39% |
| Income Before Tax | -28.35% | -26.28% | -20.09% | -47.34% | -10.23% |
| Income Tax Expenses | 44.28% | 929.41% | 473.08% | 517.54% | 138.73% |
| Earnings from Continuing Operations | -57.49% | -70.14% | -67.20% | -78.36% | -61.49% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -57.49% | -70.14% | -67.20% | -78.36% | -61.49% |
| EBIT | -11.14% | -12.06% | -13.06% | -13.63% | -14.39% |
| EBITDA | -8.78% | -7.73% | -6.89% | -6.76% | -7.92% |
| EPS Basic | -58.18% | -70.52% | -67.52% | -78.50% | -61.89% |
| Normalized Basic EPS | -13.52% | -14.92% | -10.31% | -13.84% | -17.23% |
| EPS Diluted | -60.09% | -71.18% | -67.62% | -78.63% | -62.10% |
| Normalized Diluted EPS | -15.04% | -15.27% | -9.84% | -13.49% | -17.09% |
| Average Basic Shares Outstanding | 1.00% | 0.98% | 0.98% | 0.95% | 0.91% |
| Average Diluted Shares Outstanding | 2.32% | 1.29% | 0.45% | 0.52% | 0.81% |
| Dividend Per Share | -86.67% | -90.70% | -92.86% | -69.64% | -46.43% |
| Payout Ratio | -0.70% | -0.74% | -0.77% | 0.37% | 0.39% |